Anna Van Rhenen
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Posttransplant cells for the win? DLI and adoptive cell therapy to eradicate MRD.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: November 20, 2025
Cardiovascular Disease Risk in Adults With Hematological Malignancies: A Population-Based Cohort Study Using Linked Databases.
Journal: Journal of the American College of Cardiology
Published: November 04, 2025
Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/ refractory acute myeloid leukemia.
Journal: Haematologica
Published: May 08, 2025
αβT/CD19-depleted Allogeneic Stem Cell Transplantation in Adults with Inborn Errors of Immunity.
Journal: Journal of clinical immunology
Published: April 15, 2025
Pure white cell aplasia following allogeneic hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation
Published: April 14, 2025
Heart failure in patients with acute myeloid leukemia (AML) treated with anthracycline agents during remission induction therapy: a systematic review and meta-analysis.
Journal: Leukemia
Published: March 28, 2025
Clinicians' experiences, perspectives, barriers, and facilitators of integrating palliative care into hematological malignancy care: a qualitative interview study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 23, 2025
Morning administration of anthracyclines is associated with a lower risk of cancer therapy-related cardiac dysfunction.
Journal: European heart journal open
Published: February 16, 2025
Post-intrathecal chemotherapy-related paraplegia syndrome in hematological cancer patients: A systematic review.
Journal: Neuro-oncology advances
Published: January 10, 2025
Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane.
Journal: Cardio-oncology (London, England)
Published: December 06, 2024
Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study.
Journal: Seminars in arthritis and rheumatism
Published: October 13, 2024
Last Updated: 09/26/2026